Abstract: A series of new 4-aryl-2'-[(4-hydroxyphenyl)thio]-6oxo-1,6-dihydro-2,4'-bipyridine-5-carbonitriles (3a-k) and 6-amino-4aryl-2'-[(4-hydroxyphenyl)thio]-2,4'-bipyridine-5-carbonitriles (4a-h) were synthesized from 4-hydroxythiophenol (1). The reaction of 4-hydroxythiophenol with 4-acetyl-2-chloropyridine yielded 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2). Further treatment of 2 with ethyl cyanoacetate in the presence of ammonium acetate with various aromatic aldehydes furnished the compounds 3a-k. On the other hand, condensation of 2 with aromatic aldehydes in the presence of alcoholic malononitrile in ammonium acetate gave compounds 4a-h. The structures of the newly synthesized compounds were established on the basis of their elemental analysis, as well as their IR, 1 H-and 13 C-NMR and mass spectral data. All the title compounds were subjected to in vitro antibacterial testing against two strains and antifungal screening against two fungi. Some of the compounds showed promising activity.
INTRODUCTION
The pyridine skeleton is of great importance to chemists as well as to biologists as it is found in a large variety of naturally occurring compounds and also in clinically useful molecules having diverse biological activities. Its derivatives are known to possess antitubercular, 1 anti-ulcer, 2 antimicrobial, [3] [4] [5] [6] antineoplastic, 7 antitumor, [8] [9] [10] [11] [12] antiviral 13 and cardiotonic 14 properties. It has been well established that the presence of biologically active thiophenols is an important structural feature of a variety of synthetic drugs. [15] [16] [17] [18] [19] [20] [21] Encouraged by the above reports, it was planned to synthesize new 2,4'-bipyridine-5-carbonitriles carrying 734 ARABASANAGOUDA, ADHIKARI and PARAMESHWARAPPA the 4-hydroxyphenylthio moiety, aiming at an investigation of new heterocycles of enhanced pharmacological activities. The present study describes the synthesis of hitherto unreported 4-aryl-2'-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4'--bipyridine-5-carbonitriles (3a-k) and 6-amino-4-aryl-2'-[(4-hydroxyphenyl)-thio]-2,4'-bipyridine-5-carbonitriles (4a-h) and an evaluation of their in vitro antibacterial and antifungal activities. RESULTS 
AND DISCUSSION

Chemistry
The reaction sequences employed for the synthesis of the title compounds is shown in Scheme 1. The key intermediate, 1-{2-[(4-hydroxyphenyl)thio]pyridin--4-yl}ethanone (2) , required for the preparation of the target compounds was obtained by the condensation 4-hydroxythiophenol (1) with 2-chloro-4-acetylpyridine in pyridine medium. The compound 2 on treatment with aromatic aldehydes in presence of ethyl cyanoacetate and ammonium acetate in ethanolic medium yielded the compounds 4-aryl-2'-[(4-hydroxyphenyl)thio]-6oxo-1,6-dihydro-2,4'--bipyridine-5-carbonitriles (3a-k). On the other hand, condensation of 2 with aromatic aldehydes in presence of alcoholic malononitrile in ammonium acetate gave 6-amino-4-aryl-2'-[(4-hydroxyphenyl)thio]-2,4'-bipyridine-5-carbonitriles (4a-h). 
735
The structural elucidations of new compounds were based on their elemental analysis and spectral (IR, 1 H-and 13 C-NMR and mass) data. The characterization data of all the new compounds are summarized in Table I and their spectral data are given below. 13 .00 (1H, s, NH of pyridine moiety). LC-MS (m/z): 398 (M, 100 %). 13 .00 (1H, s, NH of pyridine moiety). The formation 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2) was confirmed by FTIR, 1 H-NMR, 13 C-NMR and elemental analyses. The IR spectrum of 2 exhibited absorption bands at 3066, 1700 and 1587 cm -1 due to CH 3 , C=O and aromatic C=C stretching frequencies, respectively. Its 1 H-NMR spectrum showed singlets at δ 2.45, 7.17 and 9.48 ppm, which are due to CH 3 , pyridine proton and hydroxyl proton, respectively. Further, doublets at 6.93 and 7.48 ppm are due to the aromatic protons of the 4-hydroxyphenylthio group, while the doublets at 7.35 and 8.55 ppm are due to protons of the pyridine nucleus. Its 13 3 , C 1 of 4-hydroxyphenylthio, C 3 and C 5 of 4-hydroxyphenylthio, C 3 of pyridine, C 5 of pyridine, C 2 and C 6 of 4-hydroxyphenylthio, C 4 of pyridine, C 6 of pyridine, C 4 of 4-hydroxyphenylthio, C 2 of pyridine and C=O, respectively. It was observed that the peaks due to quaternary carbons disappeared on DEPT experimentation.
4-(4-Chlorophenyl)-2'-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4'-bipyridine-5-carbonitrile (3b). IR (KBr
4-(3,4-Dimethoxyphenyl)-2'-[(4-hydroxyphenyl)thio]-6oxo-1,6-dihydro-2,4'--bipyridine-5-carbonitrile (3c). IR (KBr
4-(3-Hydroxy-4-methoxyphenyl)-2'-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4'-bipyridine-5-carbonitrile (3d). IR (KBr
4-(4-N,N-Diethylamino-2-hydroxyphenyl)-2'-[(4-hydroxyphenyl)thio]-6oxo-1,6--dihydro-2,4'-bipyridine-5-carbonitrile (3e)
.
2'-[(4-Hydroxyphenyl)thio]-4-(4-methylphenyl)-6-oxo-1,6-dihydro-2,4'-bipyridine-5-carbonitrile (3f
4-(4-Biphenylyl)-2'-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4'-bipyridine-5-carbonitrile (3h). IR (KBr
6-Amino-2'-[(4-hydroxyphenyl)thio]-4-(4-methoxyphenyl)-2,4'-bipyridine-5--carbonitrile (4b). IR (KBr
6-Amino-4-(3,4-dimethoxyphenyl)-2'-[(4-hydroxyphenyl)thio]-2,4'-bipyridine-5-carbonitrile (4c). IR (KBr
6-Amino-2'-[(4-hydroxyphenyl)thio]-4-(4-methylphenyl)-2,4'-bipyridine-5-carbonitrile (4d). IR (KBr
6-Amino-4-(3-hydroxy-4-methoxyphenyl)-2'-[(4-hydroxyphenyl)thio]-2,4'-bipyridine-5-carbonitrile (4e). IR (KBr
6-Amino-4-(4-biphenylyl)-2'-[(4-hydroxyphenyl)thio]-2,4'-bipyridine-5-carbonitrile (4f). IR (KBr
6-Amino-4-(2-amino-3-pyridyl)-2'-[(4-hydroxyphenyl)thio]-2,4'-bipyridine--5-carbonitrile (4g)
6-Amino-2'-[(4-hydroxyphenyl)thio]-4-(2,3,5-trihydroxyphenyl)-2,4'-bipyridine-5-carbonitrile (4h). IR (KBr
The build up of 2'-[(4-hydroxyphenyl)thio]-6-oxo-4-phenyl-2,4'-bipyridine--5-carbonitrile (3a) was established on the basis of FTIR, 1 H-NMR, 13 C-NMR, mass spectral and elemental analyses. Its IR spectrum exhibited peaks at 2920, 2218, 1640 and 1590 cm -1 due to stretching frequencies of CH 3 , C≡N, C=O and C=C groups, respectively. Its 1 H-NMR spectrum exhibited two doublets at δ 6.90 and 7.41 ppm, due to the presence of the 4-hydroxyphenylthio moiety, and one multiplet for five protons at 7.60 ppm due to phenyl group at the position 4. Also, it appeared as a multiplet at 7.70 ppm, integrating for three protons, due to the pyridine rings and a doublet at 8.5 ppm due to the C 6 -H of pyridine. The OH and pyridine -NH protons appeared at δ 10.00 and 13.00 ppm, respectively. The LC--mass spectrum displayed the molecular ion peak at m/z 398.1 (M+1, 100 %), which is in agreement with the molecular formula C 23 H 15 N 3 O 2 S.
The structure of 6-amino-4-chlorophenyl-2'-[(4-hydroxyphenyl)thio]-2,4'-bipyridine-5-carbonitrile (4a) was established on the basis of FTIR, 1 H-NMR, mass spectral and elemental analyses. The IR spectrum exhibited peaks at 3468, 2216 and 1579 cm -1 , which are due to the presence of NH 2 , CN and C=C groups, respectively. The 1 H-NMR spectrum exhibited doublets at δ 6.90 and 7.40 ppm, which are due to the four protons of the 4-hydroxyphenylthio moiety. The appearance of a multiplet at 7.55-7.75 ppm is due to seven aromatic protons of the pyridines and aryl moiety. Furthermore, the appearance of a doublet at δ 8.50 ppm is due to C 6 -H of the pyridine moiety. In addition, the proton of the hydroxyl group resonates at δ 10 ppm as a broad singlet. The FAB mass spectrum showed the molecular ion peak at m/z 431(M+1, 100 %), which is in accordance with the molecular formula C 23 H 15 ClN 4 OS.
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Biological screening
Antibacterial activity. All the title compounds, 3a-k and 4a-h, were evaluated for their in vitro antibacterial activity against two bacteria, viz., Staphylococcus aureus and Escherichia coli, using the cup plate method. 22, 23 The solvent, N,N-dimethylformamide, showed no zone of inhibition. The activities were compared with the known standard drug gentamycin, used at a concentration of 1000 ppm. The results are summarized in Table II . Results of antibacterial studies revealed that compounds 3f and 3g showed fairly good activity against both the strains, while compounds 4b, 4e and 4g showed good activity against S. aureus, and the remaining compounds exhibited moderate activity, compared to the standard gentamycin. The enhanced antibacterial activity in the compounds is attributed to the presence of 4-methylphenyl and 4-methoxyphenyl groups at the position 4 of the pyridine ring.
Antifungal activity. All the title compounds, 3a-k and 4a-h, were screened for their in vitro antifungal activity against Aspergillus niger and Candida albicans using the cup plate method. 22, 23 The solvent, N,N-dimethylformamide 742 ARABASANAGOUDA, ADHIKARI and PARAMESHWARAPPA
General procedure for the preparation of 6-amino-4-aryl-2'-[(4-hydroxyphenyl)thio]-2,4'--bipyridine-5-carbonitriles (4a-h)
A mixture of 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2) (1.0 mmol), an aromatic aldehyde (1.0 mmol), malononitrile (1.0 mmol), ammonium acetate (4.0 mmol) and 10 mL of ethanol was heated at reflux for 6 h. The reaction mixture was left overnight and the separated solids were filtered and recrystallized from ethanol.
CONCLUSIONS
The successful syntheses of two series of heterocyclic title compounds and an evaluation of the antimicrobial activity of the new pyridines containing the 4-hydroxyphenylthio group were reported. From the results of the antimicrobial screening, it can be concluded that compound 3g was found to be active against both bacteria and fungi. The activity is due to the presence of 4-methoxyphenyl group in the structure.
